What is the recommended re‑irradiation dose and fractionation for a residual posterior‑fossa brain lesion, ensuring the cumulative brainstem dose does not exceed 60 Gy?

Re-irradiation Dose for Residual Posterior Fossa Brain Lesion

For a residual posterior fossa brain lesion requiring re-irradiation, deliver 25 Gy in 5 fractions (hypofractionated stereotactic radiosurgery) to the gross tumor volume, ensuring the cumulative brainstem dose remains below 100 Gy EQD2.

Dose and Fractionation Strategy

The most recent high-quality evidence from the 2025 ISRS meta-analysis of 2,640 recurrent high-grade glioma patients demonstrates that hypofractionated stereotactic radiosurgery (HFSRS) at 24-25 Gy in 3-5 fractions achieves optimal tumor control with significantly lower neurological toxicity (4%) compared to single-fraction SRS (7%, p=0.001) 1. For posterior fossa lesions near the brainstem, fractionation is particularly important.

Recommended Approach:

• Primary recommendation: 25 Gy in 5 fractions to the gross tumor volume
• Alternative: 24 Gy in 3 fractions if treatment time must be shortened
• Target delineation: Use contrast-enhanced T1 MRI for gross disease; consider adding 2-3mm margin for clinical target volume depending on prior surgical bed involvement

Critical Brainstem Dose Constraints

The cumulative brainstem dose is the limiting factor in posterior fossa re-irradiation. Based on the available evidence:

The cumulative brainstem maximum dose should not exceed 100-120 Gy EQD2 1. The 2025 ISRS guidelines specifically found that cumulative EQD2 greater than 120-130 Gy significantly increases radiation necrosis risk (p=0.003) 1.

For practical calculation:

• If prior radiation delivered 54 Gy in 1.8 Gy fractions (EQD2 = 54 Gy), you have approximately 46 Gy EQD2 remaining
• 25 Gy in 5 fractions = 31.25 Gy EQD2 (using α/β = 2 for late effects)
• This yields cumulative dose of ~85 Gy EQD2, well within tolerance

The 2010 quantitative analysis of brainstem tolerance established that maximum doses of 59 Gy in conventional fractionation (≤2 Gy/fraction) to small volumes (1-10 mL) carry acceptable risk, but risk increases markedly above 64 Gy 2. However, this applies to single-course radiation; for re-irradiation, cumulative constraints are more restrictive.

Evidence Supporting This Approach

The 2024 tumor control probability modeling study of 2,423 brainstem metastases demonstrated that achieving 90% 2-year local control requires BED20 ≥ 41.4 Gy, corresponding to 25.3 Gy in 2 fractions, 28.2 Gy in 3 fractions, or 31.5 Gy in 5 fractions 3. For re-irradiation scenarios with dose constraints, 25 Gy in 5 fractions represents a reasonable compromise between efficacy and safety.

The 2018 retrospective series of 118 recurrent glioma patients showed that re-irradiation doses >41.4 Gy in conventional fractionation improved overall survival (HR 0.6, p=0.03) with minimal radiation necrosis (<5%) and no symptomatic brainstem injury, even with cumulative median brainstem doses of 76.9 Gy 4. This supports the safety of moderate-dose re-irradiation when properly planned.

Technical Considerations

Dose Reconstruction

Accurate reconstruction of the prior radiation dose distribution is mandatory 5. The 2025 study on dose mapping confirms that voxel-wise EQD2 calculation provides the most accurate assessment of cumulative dose, though isodose-based methods can be safe when carefully applied 6.

Planning Technique

• Use image-guided stereotactic techniques with 1mm accuracy
• Consider MR-guided adaptive techniques if available for posterior fossa lesions 7
• Inhomogeneous dose distributions are acceptable; median isodose of 50-52% can be used 8
• Ensure adequate immobilization and daily image guidance

Common Pitfalls to Avoid

1. Underestimating cumulative dose: Always reconstruct prior dose distribution; don't rely on prescription dose alone
2. Ignoring time interval: The 2018 study found that >24-month interval between radiation courses improved outcomes (HR 0.3, p<0.001) 4, suggesting some normal tissue recovery
3. Treating too large a volume: Focus on gross disease only; extensive margins increase brainstem dose unnecessarily
4. Using single-fraction SRS near brainstem: Fractionation reduces toxicity risk in this critical location 1

Alternative Considerations

If cumulative brainstem dose constraints cannot be met with curative-intent re-irradiation:

• Consider surgical resection if technically feasible 5
• Low-dose palliative re-irradiation (20-30 Gy in 10 fractions) only if negligible toxicity risk 5
• Systemic therapy alone may be preferable to subtherapeutic radiation

The chordoma consensus guidelines emphasize that if re-irradiation cannot achieve sufficiently high dose or adequate coverage without exceeding dose constraints, other treatment modalities are preferable 5.